TransMedics Group (TMDX) Competitors $128.91 +9.37 (+7.84%) Closing price 04:00 PM EasternExtended Trading$129.00 +0.09 (+0.07%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TMDX vs. SNN, SOLV, PEN, STVN, IRTC, BLCO, GKOS, SLNO, NVST, and LIVNShould you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), Soleno Therapeutics (SLNO), Envista (NVST), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry. TransMedics Group vs. Its Competitors Smith & Nephew SNATS Solventum Penumbra Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos Soleno Therapeutics Envista LivaNova TransMedics Group (NASDAQ:TMDX) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings. Which has more volatility & risk, TMDX or SNN? TransMedics Group has a beta of 2.08, meaning that its share price is 108% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Does the media prefer TMDX or SNN? In the previous week, TransMedics Group had 7 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 11 mentions for TransMedics Group and 4 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.44 beat TransMedics Group's score of 0.75 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in TMDX or SNN? 99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are held by institutional investors. 7.0% of TransMedics Group shares are held by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate TMDX or SNN? TransMedics Group currently has a consensus price target of $130.73, suggesting a potential upside of 1.41%. Smith & Nephew SNATS has a consensus price target of $36.75, suggesting a potential upside of 0.56%. Given TransMedics Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe TransMedics Group is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.62Smith & Nephew SNATS 0 Sell rating(s) 8 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.11 Is TMDX or SNN more profitable? TransMedics Group has a net margin of 13.49% compared to Smith & Nephew SNATS's net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% Smith & Nephew SNATS N/A N/A N/A Which has better earnings & valuation, TMDX or SNN? Smith & Nephew SNATS has higher revenue and earnings than TransMedics Group. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.95$35.46M$1.9366.79Smith & Nephew SNATS$5.81B2.68$412M$2.1616.92 SummaryTransMedics Group beats Smith & Nephew SNATS on 12 of the 16 factors compared between the two stocks. Get TransMedics Group News Delivered to You Automatically Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMDX vs. The Competition Export to ExcelMetricTransMedics GroupMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.08B$7.57B$6.19B$10.60BDividend YieldN/A1.13%5.72%4.86%P/E Ratio66.7927.3229.6428.46Price / Sales9.9527.88577.46128.87Price / Cash72.6522.5936.5560.64Price / Book18.935.2512.076.53Net Income$35.46M$178.09M$3.32B$276.75M7 Day Performance11.44%-0.42%-0.16%0.20%1 Month Performance6.95%1.15%5.76%1.67%1 Year Performance8.64%2.87%65.71%32.73% TransMedics Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMDXTransMedics Group2.2614 of 5 stars$128.91+7.8%$130.73+1.4%-2.8%$4.08B$441.54M66.79210News CoverageUpcoming EarningsAnalyst UpgradeGap UpSNNSmith & Nephew SNATS3.266 of 5 stars$36.38+0.1%$36.75+1.0%+26.1%$15.55B$5.81B16.8617,349Analyst ForecastSOLVSolventum2.2764 of 5 stars$73.01+1.2%$84.89+16.3%+0.2%$12.65B$8.25B33.7922,000PENPenumbra4.7595 of 5 stars$245.13-1.6%$302.81+23.5%+22.5%$9.57B$1.19B65.274,500STVNStevanato Group1.2576 of 5 stars€25.18+3.0%N/A+44.0%€7.60B€1.19B46.465,521Positive NewsIRTCiRhythm Technologies1.4604 of 5 stars$178.72-1.7%$184.85+3.4%+134.0%$5.75B$591.84M-61.092,000Upcoming EarningsBLCOBausch + Lomb1.4544 of 5 stars$15.39+2.6%$15.70+2.0%-22.6%$5.44B$4.79B-19.7013,500News CoverageUpcoming EarningsGKOSGlaukos4.5262 of 5 stars$78.63-9.8%$116.92+48.7%-41.9%$4.56B$383.48M-48.21780Upcoming EarningsAnalyst ForecastSLNOSoleno Therapeutics4.2876 of 5 stars$65.26-0.3%$115.92+77.6%+24.7%$3.47BN/A-15.7930NVSTEnvista3.8888 of 5 stars$20.15+0.9%$21.08+4.6%+6.4%$3.35B$2.51B62.9612,300News CoverageUpcoming EarningsLIVNLivaNova2.9038 of 5 stars$53.37-0.7%$59.71+11.9%+2.9%$2.92B$1.25B-13.742,900News CoveragePositive News Related Companies and Tools Related Companies Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives iRhythm Technologies Alternatives Bausch + Lomb Alternatives Glaukos Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TMDX) was last updated on 10/23/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMDX Stock Alerts